Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Townsend, J. Carney, J. Yap, N. Hall (2004)
PET/CT today and tomorrow.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45 Suppl 1
A. Imperiale, S. Riehm, J. Braun (2013)
Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 57 2
M. Seltzer, C. Yap, D. Silverman, Joubin Meta, C. Schiepers, M. Phelps, S. Gambhir, Jyotsna Rao, P. Valk, J. Czernin (2002)
The impact of PET on the management of lung cancer: the referring physician's perspective.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 43 6
G. Treglia, S. Taralli, M. Calcagni, F. Maggi, A. Giordano, L. Bonomo (2011)
Is There a Role for Fluorine 18 Fluorodeoxyglucose-Positron Emission Tomography and Positron Emission Tomography/Computed Tomography in Evaluating Patients With Mycobacteriosis? A Systematic ReviewJournal of Computer Assisted Tomography, 35
J. Braun, R. Kessler, A. Constantinesco, A. Imperiale (2008)
18F-FDG PET/CT in sarcoidosis management: review and report of 20 casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 35
E Panagiotidis, A-M Quigley, D Pencharz, K Ardeshna, R Syed, R Sajjan (2013)
18F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorderLeuk. Lymphoma., 55
V. Graute, N. Jansen, H. Sohn, A. Becker, B. Klein, I. Schmid, S. Greil, S. Lehner, P. Bartenstein, T. Pfluger, M. Hacker (2012)
Diagnostic role of whole-body [18F]-FDG positron emission tomography in patients with symptoms suspicious for malignancy after heart transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 31 9
D. Dierickx, T. Tousseyn, Annelies Requilé, R. Verscuren, X. Sagaert, J. Morscio, I. Wlodarska, A. Herreman, D. Kuypers, J. Cleemput, F. Nevens, L. Dupont, A. Uyttebroeck, J. Pirenne, C. Wolf‐Peeters, G. Verhoef, Lieselot Brepoels, O. Gheysens (2013)
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorderHaematologica, 98
K. Kubota, S. Matsuno, N. Morioka, S. Adachi, M. Koizumi, H. Seto, Motohisa Kojo, S. Nishioka, M. Nishimura, Hiroshi Yamamoto (2015)
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancerAnnals of Nuclear Medicine, 29
J. Thomas, Dorothy Crawford, Margaret Burke (1995)
Clinicopathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients.Journal of Clinical Pathology, 48
R. Dickson, R. Davis, J. Rea, S. Palmer (2006)
High frequency of bronchogenic carcinoma after single-lung transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 25 11
L McCormack, TI Hany, M Hubner, H Petrowsky, B Mullhaupt, A Knuth (2006)
How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? In four patients with PTLD investigated with PET/CT, this method provided new information that changed medical management in three of the four patientsAm. J. Transplant., 6
A. Parker, Kristin Bowles, J. Bradley, V. Emery, C. Featherstone, G. Gupte, R. Marcus, J. Parameshwar, A. Ramsay, C. Newstead (2010)
Diagnosis of post‐transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS GuidelinesBritish Journal of Haematology, 149
Ji-gang Yang, H. Zhuang (2015)
The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.Hellenic journal of nuclear medicine, 18 2
R. Wiener, Lisa Schwartz, S. Woloshin, H. Welch (2011)
Population-based risk of complications following transthoracic needle lung biopsy of a pulmonary noduleAnnals of Internal Medicine, 155
T. Kwee, R. Kwee (2008)
Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysisEuropean Radiology, 19
I. Penn, T. Starzl (1972)
Malignant tumors arising de novo in immunosuppressed organ transplant recipients.Transplantation, 14
T. Kazama, S. Faria, V. Varavithya, S. Phongkitkarun, Hisao Ito, H. Macapinlac (2005)
FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls.Radiographics : a review publication of the Radiological Society of North America, Inc, 25 1
B. Mahíllo, Mar Carmona, M. Álvarez, S. White, L. Noel, R. Matesanz (2011)
2009 Global Data in Organ Donation and Transplantation: Activities, Laws, and OrganizationTransplantation, 92
M. Eiro, T. Katoh, Tsuyoshi Watanabe (2005)
Risk factors for bleeding complications in percutaneous renal biopsyClinical and Experimental Nephrology, 9
J. Helderman, W. Bennett, D. Cibrik, D. Kaufman, A. Klein, S. Takemoto (2003)
Immunosuppression: practice and trendsAmerican Journal of Transplantation, 3
M. Kim, 장은혜, Eun-Jae Lee, 나현욱, 권순억 (2010)
[18F]-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography로 진단된 전대동맥염에 의한 재발성 뇌경색Korean Journal of Stroke, 12
A Humar, M Michaels (2006)
AST ID working group on infectious disease monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantationAm. J. Transplant., 6
G Opelz, B Döhler (2004)
Lymphomas after solid organ transplantation: a collaborative transplant study report: lymphomas after solid organ transplantationAm. J. Transplant., 4
K. Watt, R. Pedersen, W. Kremers, J. Heimbach, W. Sanchez, G. Gores (2009)
Long-term probability of and mortality from de novo malignancy after liver transplantation.Gastroenterology, 137 6
W. Okumura, T. Iwasaki, T. Toyama, T. Iso, M. Arai, N. Oriuchi, K. Endo, T. Yokoyama, Tadashi Suzuki, M. Kurabayashi (2004)
Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45 12
G. Opelz, B. Döhler (2004)
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation, 4
S. Caillard, R. Porcher, F. Provôt, J. Dantal, S. Choquet, A. Durrbach, E. Morelon, V. Moal, B. Janbon, E. Alamartine, C. Noble, D. Morel, N. Kamar, M. Buchler, M. Mamzer, M. Peraldi, C. Hiesse, É. Renoult, O. Toupance, J. Rerolle, S. Delmas, P. Lang, Y. Lebranchu, A. Heng, J. Rebibou, C. Mousson, D. Glotz, J. Rivalan, A. Thierry, I. Étienne, M. Moal, L. Albano, J. Subra, N. Ouali, P. Westeel, M. Delahousse, R. Génin, B. Ligny, B. Moulin (2013)
Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 10
S. Guy, A. Tramontana, L. Worth, E. Lau, R. Hicks, J. Seymour, K. Thursky, M. Slavin (2012)
Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 39
C. Vajdic, M. Leeuwen (2009)
Cancer incidence and risk factors after solid organ transplantationInternational Journal of Cancer, 125
N. Bakker, G. Imhoff, E. Verschuuren, W. Son (2007)
Presentation and early detection of post‐transplant lymphoproliferative disorder after solid organ transplantationTransplant International, 20
Mitchell Cohen, H. A-Kader, Donna Lambers, James Heubi (1992)
Complications of percutaneous liver biopsy in children.Gastroenterology, 102 2
M. Mamede, T. Higashi, M. Kitaichi, K. Ishizu, T. Ishimori, Y. Nakamoto, K. Yanagihara, Mio Li, F. Tanaka, H. Wada, T. Manabe, T. Saga (2005)
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.Neoplasia, 7 4
A. Imperiale, J. Garnon, P. Bachellier, A. Gangi, I. Namer (2015)
Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach.Clinical nuclear medicine, 40 6
T. Pruett (2012)
2009 Global Data in Organ Donation and Transplantation: Activities, Laws, and OrganizationYearbook of Surgery, 2012
RS Wiener, LM Schwartz, S Woloshin, HG Welch (2011)
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge recordsAnn. Intern. Med., 155
L. Tsao, E. Hsi (2007)
The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders.Archives of pathology & laboratory medicine, 131 8
A. Anastasiadis, Ł. Zapała, E. Cordeiro, A. Antoniewicz, G. Dimitriadis, T. Reijke (2013)
Complications of prostate biopsyExpert Review of Anticancer Therapy, 13
Anna Taylor, R. Marcus, J. Bradley (2005)
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.Critical reviews in oncology/hematology, 56 1
F. Jamar, J. Buscombe, A. Chiti, P. Christian, D. Delbeke, K. Donohoe, O. Israel, J. Martín-Comín, A. Signore (2013)
EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection*The Journal of Nuclear Medicine, 54
Francois Cornelis, M. Silk, H. Schöder, H. Takaki, J. Durack, J. Erinjeri, C. Sofocleous, R. Siegelbaum, M. Maybody, Stephen Solomon (2014)
Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 41
M. Sathekge, A. Maes, M. Kgomo, A. Stoltz, C. Wiele (2011)
Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated TuberculosisThe Journal of Nuclear Medicine, 52
P. Shyn (2013)
Interventional positron emission tomography/computed tomography: state-of-the-art.Techniques in vascular and interventional radiology, 16 3
C Richardson, K Pointon, A. Manhire, J Macfarlane (2002)
Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies.The British journal of radiology, 75 897
A. Humar, M. Michaels (2006)
American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ TransplantationAmerican Journal of Transplantation, 6
Laure Fédérici, Cyrille Blondet, A. Imperiale, Jean Sibilia, Jean-Louis Pasquali, F. Pflumio, Bernard Goichot, G. Blaison, Jean-Christophe Weber, Daniel Christmann, André Constantinesco, Emmanuel Andrès (2010)
Value of 18F‐FDG‐PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experienceInternational Journal of Clinical Practice, 64
C. Yap, M. Seltzer, C. Schiepers, S. Gambhir, J. Rao, M. Phelps, P. Valk, J. Czernin (2001)
Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42 9
E. Sturm, E. Rings, E. Schölvinck, A. Gouw, R. Porte, J. Pruim (2006)
Fluordeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown originLiver Transplantation, 12
L. McCormack, T. Hany, M. Hübner, Henrik Petrowsky, B. Müllhaupt, Alexander Knuth, Frank Stenner, P. Clavien (2006)
How Useful is PET/CT Imaging in the Management of Post‐Transplant Lymphoproliferative Disease After Liver Transplantation?American Journal of Transplantation, 6
C. Falck, Britta Maecker, E. Schirg, A. Boerner, Wolfram Knapp, Christoph Klein, Michael Galanski (2007)
Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.European journal of radiology, 63 3
H. Balink, James Collins, G. Bruyn, F. Gemmel (2009)
F-18 FDG PET/CT in the Diagnosis of Fever of Unknown OriginClinical Nuclear Medicine, 34
Meng-jie Dong, Kui Zhao, Zhen-feng Liu, Guo-lin Wang, Shu-ye Yang, Guo-jun Zhou (2011)
A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin.European journal of radiology, 80 3
Joubin Meta, M. Seltzer, C. Schiepers, D. Silverman, Maryam Ariannejad, S. Gambhir, M. Phelps, P. Valk, J. Czernin (2001)
Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42 4
T. Poeppel, Bernd Krause, T. Heusner, C. Boy, A. Bockisch, G. Antoch (2009)
PET/CT for the staging and follow-up of patients with malignancies.European journal of radiology, 70 3
Nucl Med Mol Imaging (2017) 51:58–68 DOI 10.1007/s13139-016-0461-6 ISSN (print) 1869-3482 ORIGINAL ARTICLE ISSN (online) 1869-3474 F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation 1,2 3,4 5 6 Nastassja Muller & Romain Kessler & Sophie Caillard & Eric Epailly & 1,7 1 1,7 8 Fabrice Hubelé & Céline Heimburger & Izzie-Jacques Namer & Raoul Herbrecht & 1,7 1,7 Cyrille Blondet & Alessio Imperiale Received: 28 May 2016 /Revised: 8 November 2016 /Accepted: 8 November 2016 /Published online: 28 November 2016 Korean Society of Nuclear Medicine 2016 Abstract presented with unexplained inflammatory syndrome, fever Purpose Infection and malignancy represent two common of unknown origin (FUO), CMVor EBV seroconversion dur- complications after solid organ transplantation, which are of- ing post-transplant follow-up without conclusive conventional ten characterized by poorly specific clinical symptomatology. imaging. FDG PET/CT results were compared to histology or Herein, we have evaluated the role of F-fluoro-2-deoxy-D- to the finding obtained during a clinical/imaging follow-up glucose (FDG) positron emission tomography/computed to- period of at least 6 months after PET/CT study. mography (PET/CT) in this clinical setting. Results Positive FDG PET/CT results were obtained in Methods Fifty-eight consecutive patients who underwent 18 (31 %) patients.
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Nov 28, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.